Disease | pleural effusion disorder |
Phenotype | C0023473|chronic myelogenous leukemia |
Sentences | 2 |
PubMedID- 20463821 | Objectives: to develop an economic analysis of the management of pleural effusions in patients with imatinib-resistant/intolerant chronic myelogenous leukemia (cml). |
PubMedID- 20191333 | Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase. |
Page: 1